Gene Mack, CFO and Interim CEO at Gain Therapeutics, Inc. (GANX), bought 14,400 shares at $1.01 ($15K) on 2024-08-09, disclosed to the SEC on 2024-08-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.